Reviewed profile

food and beverage brand · public preview

Ice Bär

Retail brand

Public category
Retail brand
Products tracked
1
Brand tier
mainstream brand
Headquarters
United States
Is this your company?Claim Ice Bär to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Ice Bär — no cold outreach.
Report a changeLog in for full recordLast reviewed 5 May 2026 · public preview data

Overview

What Ice Bär covers.

Ice Bear Therapeutics is a biotechnology company focused on developing more efficient, sustainable methods for manufacturing insulin. The company utilizes mammalian cell line technology and continuous manufacturing bioreactors to produce biosimilar insulin products, including Lispro and Glargine. Headquartered in the United States, the firm operates as a social purpose company aiming to increase the global supply and affordability of life-saving diabetes treatments.

  • Talio tracks 1 product for Ice Bär.
  • Positioned as a mainstream brand.
  • Headquartered in United States.

FAQ

Questions this page answers.

What does Ice Bär do?

Ice Bär is a food and beverage brand based in United States, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.